Advertisement
CANF vs CMMB
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CANF is a Hold and CMMB is a Hold.
CANF in -3.17% downward trend, declining for three consecutive days on October 22, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where CANF declined for three days, in 277 of 320 cases, the price declined further within the following month. The odds of a continued downward trend are 87%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 25, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CANF as a result. In 74 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.
The Aroon Indicator for CANF entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CANF's RSI Indicator exited the oversold zone, 38 of 46 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 49 of 69 cases where CANF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.
The Moving Average Convergence Divergence (MACD) for CANF just turned positive on October 19, 2026. Looking at past instances where CANF's MACD turned positive, the stock continued to rise in 31 of 38 cases over the following month. The odds of a continued upward trend are 82%.
Following a +1.38% 3-day Advance, the price is estimated to grow further. Considering data from situations where CANF advanced for three days, in 154 of 198 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
CANF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 56 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.834) is normal, around the industry mean (2.973). P/E Ratio (-0.407) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (8.621) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 86 (best 1 - 100 worst), indicating slightly worse than average price growth. CANF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CANF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
CMMB in downward trend: price dove below 50-day moving average on September 28, 2026
CMMB moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend. In 38 of 40 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CMMB as a result. In 67 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.
The 10-day moving average for CMMB crossed bearishly below the 50-day moving average on October 01, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 16 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 89%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CMMB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CMMB entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 18 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +20.17% 3-day Advance, the price is estimated to grow further. Considering data from situations where CMMB advanced for three days, in 198 of 235 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
CMMB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 43 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.911) is normal, around the industry mean (2.973). P/E Ratio (-1.125) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 90 (best 1 - 100 worst), indicating slightly worse than average price growth. CMMB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CMMB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
CANF | CMMB | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 81 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 56 Fair valued | 43 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 98 | |
PRICE GROWTH RATING 1..100 | 86 | 90 | |
P/E GROWTH RATING 1..100 | 12 | 17 | |
SEASONALITY SCORE 1..100 | 50 | 27 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CMMB's Valuation (43) in the Biotechnology industry is in the same range as CANF (56). This means that CMMB’s stock grew similarly to CANF’s over the last 12 months.
CMMB's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CANF (100). This means that CMMB’s stock grew similarly to CANF’s over the last 12 months.
CMMB's SMR Rating (98) in the Biotechnology industry is in the same range as CANF (100). This means that CMMB’s stock grew similarly to CANF’s over the last 12 months.
CANF's Price Growth Rating (86) in the Biotechnology industry is in the same range as CMMB (90). This means that CANF’s stock grew similarly to CMMB’s over the last 12 months.
CANF's P/E Growth Rating (12) in the Biotechnology industry is in the same range as CMMB (17). This means that CANF’s stock grew similarly to CMMB’s over the last 12 months.
| CANF | CMMB | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 83% | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 71% | 1 day ago 84% |
| Momentum ODDS (%) | 1 day ago 86% | 1 day ago 89% |
| MACD ODDS (%) | 1 day ago 82% | N/A |
| TrendWeek ODDS (%) | 1 day ago 86% | 1 day ago 90% |
| TrendMonth ODDS (%) | 1 day ago 86% | 1 day ago 90% |
| Advances ODDS (%) | 22 days ago 78% | 21 days ago 84% |
| Declines ODDS (%) | 1 day ago 87% | 1 day ago 90% |
| BollingerBands ODDS (%) | 1 day ago 79% | 1 day ago 86% |
| Aroon ODDS (%) | 1 day ago 87% | 1 day ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CANF’s FA Score shows that 1 FA rating(s) are green while CMMB’s FA Score has 1 green FA rating(s).
- CANF’s FA Score: 1 green, 4 red.
- CMMB’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CANF’s TA Score shows that 5 TA indicator(s) are bullish while CMMB’s TA Score has 4 bullish TA indicator(s).
- CANF’s TA Score: 5 bullish, 3 bearish.
- CMMB’s TA Score: 4 bullish, 5 bearish.
Price Growth
CANF (@Biotechnology) experienced а -2.09% price change this week, while CMMB (@Biotechnology) price change was -10.85% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.
Reported Earning Dates
CMMB is expected to report earnings on Oct 22, 2026.
Industries' Descriptions
@Biotechnology (-1.10% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
CANF and
Correlation & Price change
A.I.dvisor indicates that over the last year, CANF has been closely correlated with GNPX. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if CANF jumps, then GNPX could also see price increases.
| Ticker / NAME | Correlation To CANF | 1D Price Change % | ||
|---|---|---|---|---|
| CANF | 100% | -3.15% | ||
| GNPX - CANF | 93% Closely correlated | -3.41% | ||
| ICU - CANF | 91% Closely correlated | -10.09% | ||
| MLEC - CANF | 89% Closely correlated | +1.51% | ||
| LONA - CANF | 78% Closely correlated | -12.35% | ||
| LNAI - CANF | 72% Closely correlated | -9.27% | ||
More | ||||
CMMB and
Correlation & Price change
A.I.dvisor indicates that over the last year, CMMB has been loosely correlated with CANF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CMMB jumps, then CANF could also see price increases.
| Ticker / NAME | Correlation To CMMB | 1D Price Change % | ||
|---|---|---|---|---|
| CMMB | 100% | -6.09% | ||
| CANF - CMMB | 45% Loosely correlated | -3.15% | ||
| AXON - CMMB | 37% Loosely correlated | +2.98% | ||
| SPRB - CMMB | 36% Loosely correlated | +7.65% | ||
| CRSP - CMMB | 34% Loosely correlated | -1.01% | ||
| EDIT - CMMB | 31% Poorly correlated | -0.80% | ||
More | ||||